Miranza’s R&D&I teams are already working on the clinical trial of the VEMoS Project by collecting samples from 1,400 eyes at Miranza IOA and at Vissum Grupo Miranza, the centre where the system’s code is being processed, as well as at two European centres: Portugal (Centro Hospitalar e Universitário de Coimbra) and Denmark (Aarhus Universitetshospital).
